Arous Salim, Haboub Meryem, El Ghali Benouna Mohamed, Bentaoune Tarik, Habbal Rachida
Department of Cardiology, Ibn Rushd University Hospital, Casablanca, Morocco.
J Med Case Rep. 2017 Jun 11;11(1):154. doi: 10.1186/s13256-017-1322-3.
Hemorrhagic complications are quite common in the rare cases where thrombolysis is performed. Ischemic stroke in the aftermath of thrombolysis for a ST elevation myocardial infarction is a very rare and paradoxical complication. With these observations in mind we report two interesting cases of ischemic stroke which occurred after fibrinolytic therapy with tenecteplase for a ST elevation myocardial infarction.
The first case was a 56-year-old African man who presented with an acute infero-basal ST elevation myocardial infarction 6 hours after chest pain onset. Thrombolysis with tenecteplase was performed and few minutes later an ischemic stroke occurred. The second patient was a 65-year-old African man who presented with an acute infero-basal ST elevation myocardial infarction 5 hours after chest pain onset. Thrombolysis was performed and 10 hours later an ischemic stroke occurred.
Hemorrhagic stroke is not the only complication of thrombolysis, ischemic stroke can occur even if it is an extremely rare complication. The two cases on which we report shed light on the association between fibrinolytic therapy and ischemic stroke, the pathophysiology of which is not well understood.
在进行溶栓治疗的罕见病例中,出血并发症相当常见。ST段抬高型心肌梗死溶栓治疗后发生缺血性卒中是一种非常罕见且自相矛盾的并发症。鉴于这些观察结果,我们报告两例有趣的病例,均为在使用替奈普酶进行纤维蛋白溶解疗法治疗ST段抬高型心肌梗死后发生缺血性卒中。
第一例是一名56岁的非洲男性,在胸痛发作6小时后出现急性下基底ST段抬高型心肌梗死。进行了替奈普酶溶栓治疗,几分钟后发生缺血性卒中。第二例患者是一名65岁的非洲男性,在胸痛发作5小时后出现急性下基底ST段抬高型心肌梗死。进行了溶栓治疗,10小时后发生缺血性卒中。
出血性卒中并非溶栓治疗的唯一并发症,即使缺血性卒中是极其罕见的并发症,也可能发生。我们报告的这两例病例揭示了纤维蛋白溶解疗法与缺血性卒中之间的关联,其病理生理学尚未完全明确。